Doctors Are Split Down the Middle
Medical experts are anything but unanimous on this trend. Some say Ozempic could help fight America’s obesity crisis, which affects nearly 42% of adults. Others worry that mass adoption could lead to long-term consequences we simply don’t understand yet.
Endocrinologists caution that semaglutide hasn’t been around long enough to know the full story. Sure, early trials show weight loss. But what about 10 or 20 years down the road? Could there be hidden risks? No one knows.